dr. reddy's labs (UBS) Q4FY11: Strong beat

Q4FY11 Sales: Rs 20bn (+23% YoY, +6% QoQ);; EBITDA: Rs 4.4bn (+25% YoY, +15%qoq); PAT Rs 3.35bn (+23%qoq); Valuation: Maintain Buy, PT Rs 2,000
Date Rating Target Price Recommendation Price Broker house
16 May 2011 buy 2000 1655 UBS Report

No comments:

Post a Comment